elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26739969-F232FA62-E795-495A-9808-83548FBE9C4B
Q26739969-F232FA62-E795-495A-9808-83548FBE9C4B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26739969-F232FA62-E795-495A-9808-83548FBE9C4B
Tamoxifen Resistance: Emerging Molecular Targets
P2860
Q26739969-F232FA62-E795-495A-9808-83548FBE9C4B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26739969-F232FA62-E795-495A-9808-83548FBE9C4B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7387fa5506afa8a5a663b3d88db9eaa4c9386b5c
P2860
In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.